Sensitivity to gains during risky decision-making differentiates chronic cocaine users from stimulant-naïve controls by Kluwe-Schiavon, B et al.








Sensitivity to gains during risky decision-making differentiates chronic
cocaine users from stimulant-naïve controls
Kluwe-Schiavon, B ; Kexel, A ; Manenti, G ; Cole, D M ; Baumgartner, M R ; Grassi-Oliveira, R ;
Tobler, Philippe N ; Quednow, Boris B
Abstract: Background Chronic cocaine use has been consistently associated with decision-making im-
pairments that contribute to the development and maintenance of drug-taking. However, the underlying
cognitive processes of risk-seeking behaviours observed in chronic cocaine users (CU) have so far remained
unclear. Here we therefore tested whether CU differ from stimulant-naïve controls in their sensitivity to
gain, loss, and probability of loss information when making decisions under risk. Method A sample of
96 participants (56 CU and 40 controls) performed the no-feedback version of the Columbia Card Task,
designed to assess risk-taking in relation to gain, loss, and probability of loss information. Additionally,
cognitive performance and impulsivity were determined. Current and recent substance use was objectively
assessed by toxicological urine and hair analysis. Results Compared to controls, CU showed increased
risk-seeking in unfavourable decision scenarios in which the loss probability was high and the returns were
low, and a tendency for increased risk aversion in more favourable decision scenarios. In comparison to
controls, CU were less sensitive to gain, but similarly sensitive to loss and probability of loss information.
Further analysis revealed that individual differences in sensitivity to loss and probability of loss informa-
tion were related to cognitive performance and impulsivity. Conclusion Reduced sensitivity to gains in
people with CU may contribute to their propensity for making risky decisions. While these alterations
in gain sensitivity might directly relate to cocaine use per se, the individual psychopathological profile of
CU might moderate sensitivity to loss information.
DOI: https://doi.org/10.1016/j.bbr.2019.112386






The following work is licensed under a Creative Commons: Attribution-NonCommercial-NoDerivatives
4.0 International (CC BY-NC-ND 4.0) License.
Originally published at:
Kluwe-Schiavon, B; Kexel, A; Manenti, G; Cole, D M; Baumgartner, M R; Grassi-Oliveira, R; Tobler,
Philippe N; Quednow, Boris B (2020). Sensitivity to gains during risky decision-making differentiates
chronic cocaine users from stimulant-naïve controls. Behavioural Brain Research, 379:112386.
DOI: https://doi.org/10.1016/j.bbr.2019.112386
 1 
Sensitivity to gains during risky decision-making differentiates 
chronic cocaine users from stimulant-naïve controls 
 
Kluwe-Schiavon, B.*,1; Kexel, A.1; Manenti, G.1,2; Cole, D.M.1; Baumgartner, M.R.3 
Grassi-Oliveira, R.4; Tobler, P.N.5,6; Quednow, B.B.*,1,6 
 
1 Experimental and Clinical Pharmacopsychology; Department of Psychiatry, 
Psychotherapy, and Psychosomatics; Psychiatric Hospital, University of Zurich; Switzerland 
2 Neural Circuits and Cognition Lab, European Neuroscience Institute Göttingen, 
University Medical Center Göttingen and Max-Planck-Society, Germany 
3 Center of Forensic Hairanalytics, Institute of Forensic Medicine, University of Zurich, Switzerland 
4 Developmental Cognitive Neuroscience Laboratory; Brain Institute; 
Pontifical Catholic University of Rio Grande do Sul; Brazil 
5 Zurich Center for Neuroeconomics, Department of Economics, University of Zürich, Switzerland 







Manuscript Characteristics  
Number of words in the abstract: 242 
Number of words in the text: 5221 
Number of tables: 4 





Bruno Kluwe-Schiavon, MSc 
Clinical and Experimental Pharmacopsychology 
Department of Psychiatry, Psychotherapy 
and Psychosomatics, Psychiatric Hospital 
University of Zurich 
Lenggstrasse 31 
CH-8032 Zurich, Switzerland 
Tel.: 0041-44-384-2582   
Fax: 0041-44-384-3396 
E-Mail: bruno.kluwe@bli.uzh.ch 
Boris B. Quednow, PhD 
Clinical and Experimental Pharmacopsychology 
Department of Psychiatry, Psychotherapy  
and Psychosomatics, Psychiatric Hospital 
University of Zurich  
Lenggstrasse 31 









All authors agreed with the current version of the manuscript and approved the submission to the 
journal.  
 
Sensitivity to gains during risky decision-making differentiates 




- The reduced sensitivity to gain information in people with CU may contribute to their 
propensity for making risky decisions. 
- The individual psychopathological profile of CU might moderate their reduced 
sensitivity to risk and loss information. 




Background: Chronic cocaine use has been consistently associated with decision-making 
impairments that contribute to the development and maintenance of drug-taking. However, the 
underlying cognitive processes of risk-seeking behaviours observed in chronic cocaine users 
(CU) have so far remained unclear. Here we therefore tested whether CU differ from stimulant-
naïve controls in their sensitivity to gain, loss, and probability of loss information when making 
decisions under risk.  
Method: A sample of 96 participants (56 CU and 40 controls) performed the no-feedback 
version of the Columbia Card Task, designed to assess risk-taking in relation to gain, loss, and 
probability of loss information. Additionally, cognitive performance and impulsivity were 
determined. Current and recent substance use was objectively assessed by toxicological urine 
and hair analysis.  
Results: Compared to controls, CU showed increased risk-seeking in unfavourable decision 
scenarios in which the loss probability was high and the returns were low, and a tendency for 
increased risk aversion in more favourable decision scenarios. In comparison to controls, CU 
were less sensitive to gain, but similarly sensitive to loss and probability of loss information. 
Further analysis revealed that individual differences in sensitivity to loss and probability of loss 
information were related to cognitive performance and impulsivity.  
Conclusion: Reduced sensitivity to gains in people with CU may contribute to their propensity 
for making risky decisions. While these alterations in gain sensitivity might directly relate to 








Value-based decision-making facilitates goal-directed behaviour, which is essential for 
survival. It relates the net returns (i.e., the gains minus the losses) to the risks (e.g., the 
uncertainty of returns or probability of a loss) of different options with the aim of selecting the 
option with the highest subjective value [1-4]. Value-based decision processes can be affected by 
the degree of uncertainty associated with the decision [5], development stage [5], social context 
[6], and several psychiatric disorders [7]. Specifically, decision-making impairments constitute 
one of the main behavioural characteristics of substance-related disorders, and contribute both to 
the impulsive initiation of substance use and to the compulsive maintenance of the addictive 
behaviour [8]. Such deficits seem to be even more severe when substances with strong addictive 
potentials are involved [9, 10], such as cocaine [11, 12]. 
Despite the negative consequences of chronically using cocaine, it remains one of the 
most commonly used illicit substances [13, 14]. In addition to the immediate risk of overdose 
and intoxication, cocaine use represents a substantial burden for the individual and their families, 
as well as for society, because of its associations with cardiovascular [15], neurological [10, 16-
18], and psychiatric [19] disorders, along with with cognitive deficits [20, 21]. The negative 
consequences of cocaine use include decreases in quality of life and social functioning [3], in 
addition to increases in high-risk behaviours and drug usage [11, 22]. From a clinical 
perspective, chronic cocaine use is often accompanied by increased forgoing of occupational or 
recreational activities and by an increase in cocaine-seeking behaviours [23], which, from a 
decision-making viewpoint, suggests changes in the sensitivity of value-based decisions to the 
risks and returns of different courses of action. 
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Previous research [23, 24] suggests that chronic cocaine users (CU) are less sensitive to 
gains (i.e., the magnitude of positive outcomes) and losses (i.e., the magnitude of negative 
outcomes) in everyday situations [25, 26]. In particular, CU have been proposed to suffer from a 
generalised impairment in value representation, reflected in blunted neural responses to non-
substance-related (social and non-social) rewards, specifically in value-coding regions such as 
ventromedial prefrontal cortex [3, 27, 28]. Based on these findings, we hypothesized that the 
deficits of chronic CU in risky decision-making would partially arise from alterations in return 
sensitivity.  
Moreover, chronic cocaine use is associated with changes in brain networks involved in 
executive functioning and risk-taking, as indicated by reduced cortical thickness in the lateral 
prefrontal cortex, anterior cingulate cortex, and orbitofrontal cortex [20, 29, 30]. Such alterations 
may partially explain why CU are more likely to make maladaptive decisions in situations 
requiring implicit learning about risks, and why they prefer options with high gain, but high risk 
[31-33]. Thus, it has also been hypothesized that CU may underestimate the risk of being subject 
to adverse consequences over an extended period, resulting in long-term losses; a phenomenon 
previously described as “myopia for the future” [34, 35]. This tendency to chase short-term 
reward, potentially at the expense of developing rules that maximize reward over the long term, 
may be a contributing factor to addiction disorders in general, as it has also been observed in 
opioid users [36]. 
Importantly, although the literature suggests that CU may show impaired weighing or 
estimation of risks and returns in value-based decisions, thus far no study has investigated 
whether CU show decreased sensitivity specifically to information about gain magnitude, loss 
magnitude, and/or the probability of loss (i.e., one form of risk). Moreover, it has remained 
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unclear whether such alterations can explain their risk-taking behaviour in decisions with varying 
expected value. Here, we used the no-feedback (“cold”) version of the CCT [37] to investigate 
whether CU differ from stimulant-naïve controls in the sensitivity to gain, loss, and probability 
of loss information when making decisions under risk. The no-feedback CCT version was used 
because it is designed to trigger deliberative processes, leading participants to base their choices 
mostly on reasoning instead of affective-emotional processes [38-40]. Based on the blunted 
neural responses to non-drug rewards observed in CU [27], we hypothesized that CU would be 
less sensitive to gain information compared to the control group.  
In addition, we also aimed to investigate the effects of demographic, cognitive, 
psychopathological, and substance use severity variables on the sensitivity to gain, loss, and 
probability of loss information. Previous studies indicate that self-reported impulsivity and 
gambling behaviour are strongly state-dependent in CU [41], and that the often comorbid 
symptoms of attention deficit hyperactivity disorder (ADHD) aggravate the effects of cocaine 
use on cognitive impairment [42, 43]. We therefore hypothesized that both trait impulsivity and 
ADHD symptoms would reduce the sensitivity of CU to gain, loss, and probability of loss 
information. Investigating possible effects of ADHD on information sensitivity is important 
because reward processing deficits in ADHD are still present during adulthood and have been 
related to changes in prefrontal activity during decision-making [44]. Finally, using both self-
reports and hair samples allowed us to explore whether subjective and objective measures of 
cocaine use severity relate to the sensitivity to gain, loss, and probability of loss in the CCT. 
Overall, we investigate how chronic cocaine use, as well as demographic, clinical, and cognitive 
factors, affect sensitivity to gain, loss, and probability of loss information in value-based 
decisions. Our findings provide a basis for allowing a better understanding of the proclivity of 
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CU for risky behaviours. This knowledge may provide new leads towards improving the 




The data were collected in the context of the “Stress and Social Cognition Study” (SCPP) 
at the Psychiatric Hospital of the University of Zurich. In this study, a total sample of 123 
participants (69 chronic CU and 54 stimulant-naïve controls) was assessed (for detailed 
information on recruitment procedures, please see Supplementary Material). CU were included 
in the study if cocaine was the primary illegal drug they used, if a lifetime cumulative 
consumption of at least 100g of cocaine was estimated by self-report and if their current 
abstinence duration was <6 months. Exclusion criteria comprised a family history of genetically 
mediated psychiatric disorders (h
2
>0.5, e.g., autism, schizophrenia, and bipolar disorder); any 
severe neurological disorder or brain injury; a current diagnosis of infectious diseases or severe 
somatic disorder; a history of autoimmune, endocrine, and rheumatoid arthritis; intake of 
medication with potential action at the central nervous system during the last seven days; 
participation in a large previous study from our lab, the Zurich Cocaine Cognition Study [42, 
45]; and for women being pregnant or breastfeeding. Controls were excluded if they had DSM-
IV-R Axis I adult psychiatric disorders, or recurrent illegal substance use (>15 occasions 
lifetime, with the exception of cannabis for reasons of participant matching). We excluded CU 
with regular use of illegal substances other than cocaine, such as heroin or other opioids (with 
the exception of cannabis use), a polysubstance use pattern according to DSM-IV-R, or a DSM-
IV axis I adult psychiatric disorder diagnosis (e.g., schizophrenia, bipolar disorder, current major 
depressive episode, eating disorders, current anxiety disorder) except for cocaine, cannabis, and 
alcohol abuse/dependence, previous depressive episodes, and ADHD. 
After applying the exclusion criteria, a total sample of 99 participants (59 chronic CU and 
40 stimulant-naïve controls) was considered. However, two participants could not perform the 
CCT for technical reasons and one participant was excluded because the CCT data revealed 
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random responses, suggesting that they did not understand the task or were not sufficiently 
motivated to perform. Therefore, 96 participants (56 chronic CU and 40 stimulant-naïve 
controls) matched for sex, age, smoking status, and weekly alcohol use (average number of times 
people drink per week) were analysed in this study. The study was approved by the Cantonal 
Ethics Committee of Zurich (BASEC ID 2016-00278) and preregistered with an International 
Standard Randomised Controlled Trial Number (ISRCTN-10690316). All participants provided 
written informed consent in accordance with the Declaration of Helsinki and were compensated 
for their participation. 
 
2.2 Clinical and substance-related assessment 
The psychopathological assessment was carried out with the Structured Clinical 
Interview I (SCID-I) according to DSM-IV-R [46]. ADHD symptoms were collected with the 
ADHD self-rating scale (ADHD-SR) [47]. Trait impulsivity was measured with the Barratt 
Impulsiveness Scale (BIS) [48]. Self-reported drug use was assessed with the structured and 
standardized Interview for Psychotropic Drug Consumption [49].  
 
2.3 Urine and hair toxicological analysis 
Urine analyses using a semi-quantitative enzyme multiplied immunoassay method 
targeted the following substances: amphetamines, barbiturates, benzodiazepines, cocaine, 
methadone, morphine-related opiates, and tetrahydrocannabinol. In addition, quantitative 
analysis of hair samples using liquid chromatography tandem mass spectrometry (LC-MS/MS) 
was used to investigate substance consumption over the last 4 months as represented in the 
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proximal 4 cm-segment of the hair samples. In total 88 compounds were assessed. For a 
complete description of all compounds assessed, please see Supplementary Material.  
 
2.4 General cognitive assessment 
The German vocabulary test Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B) was 
applied to estimate premorbid verbal intelligence [50]. General cognitive performance was 
assessed with three tasks from the Cambridge Neuropsychological Test Automated Battery 
(CANTAB, http://www.cantab.com). These tasks included the Spatial Working Memory task 
(SWM) (to assess working memory and executive functioning), the Match to Sample Visual 
Search task (MTS) (a visual matching test involving a trade-off of speed and accuracy), and the 
Rapid Visual Information Processing task (RVP) (to assess sustained attention capacity). For 
detailed information about these tasks, please see the Supplementary Material.  
 
2.5 Columbia Card Task 
Due to our primary focus on understanding how the sensitivity to gain, loss, and 
probability of loss information can explain people’s behaviour in different decision scenarios, 
participants performed the no-feedback condition of the CCT (see Supplementary Material). In 
the CCT, participants view a deck with 32 facedown cards and three explicit information cues 
(i.e., scenario properties). These properties include the number of losing cards hidden in the deck 
(i.e., probability of loss: 1 or 3), the amount associated with each losing card (i.e., loss: -250 or -
750 points) and the amount associated with each winning card (i.e., gain: 10 or 30 points). The 
different combinations of gain, loss, and probability of loss form eight possible decision 
 7
scenarios that can be sorted from the most favourable to the least favourable, according to the 
expected value.  
 
2.5.1. Risk-attitude 
In every round, participants decided how many cards the computer would randomly 
select and turn over, knowing that the round would end immediately if the computer selected one 
of the losing cards. The primary outcome of the CCT is the average number of cards chosen, 
which can be interpreted as a general proxy of risk-seeking behaviour, with a higher number of 
cards corresponding to greater risk-proneness [37, 51-53]. We also analysed the risk-seeking 
behaviour separately for each decision scenario in order to assess risk-taking in a more fine-
grained fashion.  
 
2.5.2. Sensitivity to gain, loss, and probability of loss 
Concerning sensitivity to the scenario properties (i.e., gain, loss, and probability of loss), 
a normative analysis of the CCT suggests that participants should choose the number of cards so 
as to maximize subjective value [37]. An optimal strategy takes into account gain, loss, and 
probability of loss. Data can be analysed at both the group and the individual level [37].  
At the group level we performed a linear mixed effect model (LMM) [54] including 
group (CU or stimulant-naïve controls), gain (10, 30), loss (-250, -750), and probability of loss 
(1, 3 loss cards) as fixed-effects. This model allowed us to extract regression coefficients for 
both group and scenario properties. The LMM accounted for the random-effects of each 
participant slope and intercept associated with the different scenario properties [54]. Because the 
regression coefficients represent the slope of the function (i.e., the weighting that gain, loss, and 
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probability of loss received in determining the number of cards), we used these values as 
measures for the sensitivity to gain, loss, and probability of loss.  
At the individual level, LMM analyses were performed for each participant separately to 
investigate how the sensitivity to gain, loss, and probability of loss influenced his/her risk-taking. 
Given that the 24 rounds of the task were randomly presented among three blocks, the blocks 
and the rounds were included as random effects in the model. The number of cards chosen was 
mean centred according to the control group. Similar to the group analysis, three coefficients 
were extracted for each participant, capturing how the participant weighted gain, loss, and 
probability of loss.  
 
2.6 Statistical analysis 
2.6.1. Demographic characteristics and substance use  
All statistical analyses were performed with the open source statistical software R [55]. 
Regarding demographic, clinical, cognitive, and substance-related variables, frequency data were 
analysed by means of Pearson’s chi-squared tests. Group data were compared by Student’s t-tests 
or, when data were non-normally distributed, Wilcoxon rank sum tests (i.e., Shapiro–Wilk W < 
.001, and skew and kurtosis divided by 2 standard errors < 2).  
 
2.6.2. Overall and scenario-specific risk-attitude 
To assess potential group differences in overall risk-attitude, independent of the decision 
scenario, we used several LMM analyses including different random intercepts and slopes and 
tested them with the model fitting function “anova” [56]. The best model included a random 
slope and intercept for each participant and scenario properties (i.e., gain, loss, and probability of 
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loss). Then, using a similar strategy of testing different random intercepts and slopes with the 
same model fitting function, the effect of group on the average number of cards chosen at each 
decision scenario was investigated including a random intercept for participant only.  
 
2.6.3. Sensitivity to gain, loss, and probability of loss 
Secondly, to investigate group differences in the sensitivity to scenario properties, we 
first performed a LMM analysis including group (CU or stimulant-naïve controls) and the 
expected value of each decision scenario as fixed-effects, and a random slope and intercept for 
each participant and the three scenario properties (gain, loss, and probability of loss). Then, as 
mentioned, a LMM analysis including group, gain, loss, and probability of loss as fixed-effects 
and a random slope and intercept for each participant and the three scenario properties was 
performed. To explore within-group variance explained by the use of information, the same 
model was also analysed for both groups separately. Effect sizes were calculated (0≤|r|<.10 small 
effect size; .10≤|r|<.30 medium effect size; .30≤|r|<.50 large effect size), which have been 
suggested as versatile measures of the strength of an experimental effect with an intuitive 
interpretation – absolute values of “r” are constrained to lie between 0 (no effect) and 1 (maximal 
effect) [57].  
 
2.6.4. Impact of demographic, cognitive, and clinical variables on gain, loss and 
probability of loss sensitivities 
In a third step, we examined whether the reported demographic, cognitive and clinical 
group differences contributed to sensitivity to gain, loss, and probability of loss for each 
participant individually. To do so, we performed hierarchical linear models including years of 
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education, verbal IQ, SWM Strategy score, SWM Total error score, meta-efficiency index, trait 
impulsivity, and ADHD symptoms. To test for multicollinearity between predictors we 
performed a set of Spearman’s rank correlations over all participants. Based on the cut-offs 
suggested by Cohen [57], predictors with large effect size correlations were not included together 
in the same model. Then, to identify the subset of variables with the highest explanatory power 
we incorporated the predictors into the model ‘one by one’. As before, models were compared 
using the model fitting function “anova” [56]. Subsequently, linear regressions were performed 
within both groups to relate individual sensitivity to gain, loss, and probability of loss to the 
average number of cards chosen in each decision scenario, controlling for the predictors with 
which a significant effect was found in the hierarchical linear models.  
 
2.4.5. Impact of cocaine use severity on gain, loss and probability of loss sensitivities 
Linear regression analyses were performed within CU to examine how cocaine-related 
variables (cocaine hair metabolites, cocaine abstinence period, cocaine years of use, and cocaine 
estimated cumulative lifetime dose) related to gain, loss, and probability of loss sensitivities. 
These analyses were run with and without controlling for the predictors with which a significant 
effect was found in the hierarchical linear models. Due to the highly right-skewed distribution 







3.1 Demographic characteristics and substance use 
As intended by our matching procedure, the groups did not differ in age or sex, as well as 
nicotine and cannabis smoking status (Table 1 and Table 2), although on average CU had fewer 
years of education than stimulant-naïve controls and lower verbal IQ. As expected, CU displayed 
higher ADHD-SR scores and higher trait impulsivity in the BIS. Moreover, CU exhibited worse 
working memory and executive functioning, measured by the SWM between/total errors and 
SWM strategy score, respectively. CU also showed lower signal detection/sustained attention in 
the RVP and lower efficiency indices in the RVP and MTS.  
Hair samples revealed a clear dominance of cocaine compared with all other illegal 
drugs, as set out by the inclusion criteria (on average 12 times more cocaine than MDMA and 25 
times more cocaine than amphetamines) (Table 2). SCID-I revealed a higher frequency of 
alcohol and cannabis-related disorders in CU compared to stimulant-naïve controls. Correlation 
analyses revealed that total hair concentrations of cocaine metabolites (Cocainetotal) were 
associated with self-reported estimated cumulative dose (r=.366, p<.01, n=56), duration of use 
(r=.326, p<.05, n=56), days of abstinence before measurement (r=-.333, p<.05, n=56), and urine 
concentrations for cocaine (r=.542, p<.001, n=56).  
 
------------------ TABLE 1 ------------------ 
 
------------------ TABLE 2 ------------------ 
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3.2 Decision-making  
3.2.1. Overall and scenario-specific risk-attitude 
To investigate group differences in overall risk-attitude, we performed a LMM including 
group as a predictor and a random slope for each participant at each scenario property. The 
analysis revealed that CU (Mean = 12.37, SD = 8.1) did not differ from stimulant-naïve controls 
(Mean = 11.67, SD = 8.5) concerning the average number of cards chosen over all decision 
scenarios (ß = .008, 95%CI = -1.84 to 1.86, t[94] = .008, p = .993, r = .0009).  
Next, we investigated risk-taking for each scenario independently by modelling a random 
intercept for each participant. We found that CU chose more cards than stimulant-naïve controls 
in high risk, low return scenarios (i.e., the most unfavourable decision scenario: ß = 3.67, 95%CI 
= 1.05 to 6.30, t[94] = 2.76, p = .006; Figure 1). This finding remained after including verbal IQ, 
years of education, and ADHD symptoms as covariates (ß = 3.50, 95%CI = 3.98 to 4.86, t[91] = 
2.31, p = .022; Figure 1). Additionally, we found that CU tended to choose fewer cards than 
stimulant-naïve controls in low risk, high return scenarios (i.e., the most favourable decision 
scenario: ß = -2.56, 95%CI = -5.27 to .14, t[94] = -1.87, p = .064; Figure 1), although this finding 
did not reach significance. Thus, CU were more risk-taking than controls in unfavourable 
decision scenarios but tended to decide more cautiously in favourable decision scenarios.  
 
------------------ FIGURE 1 ------------------ 
 
3.2.2. Sensitivity to gain, loss, and probability of loss 
To investigate group differences in overall sensitivity to the expected value, we 
performed a LMM analysis including group and expected value as fixed effects, as well as 
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random slopes and intercepts for each participant and each scenario property. The data revealed 
that CU were significantly less sensitive to expected value (ß = -.052, 95%CI = -.08 to -.02, 
t[2206] = -3.55, p = .0004, r = .075) than stimulant-naïve controls. Subsequently, to investigate 
group differences in the use of scenario properties, we performed a LMM analysis including 
group, gain, loss, and probability of loss as fixed-effects and random slopes and intercepts for 
each participant and each scenario property. As shown in Figure 2, we found a significant 
interaction of group with gain and a marginally significant interaction of group with loss. These 
interactions suggest that when gain is high and, to a lesser degree, when loss is low, CU select 
fewer cards than stimulant-naïve controls. We found no interaction of group with probability of 
loss. Moreover, as expected from the preceding analysis (section 3.2.1), main effects were found 
for gain, loss, and probability of loss but not for group. Confirming our hypothesis, these 
findings suggest that, compared to controls, CU are less sensitive to the expected value (i.e., the 
“favourableness” of the decision scenarios). In particular, CU are less sensitive to gain 
information, choosing fewer cards than controls at high gains.  
 
------------------ FIGURE 2 ------------------ 
 
To explore within-group variance explained by the use of scenario properties, we 
analysed the number of cards chosen for CU and stimulant-naïve controls separately. The control 
group displayed a significant effect of all scenario properties (gain: ß = 3.30, 95%CI = 1.70 to 
4.91, t[913] = 4.03, p < .001, r = .132; loss: ß = 2.76, 95%CI = .99 to 4.54, t[913] = 3.04, p = 
.002, r = .100; probability of loss: ß = -4.60, 95%CI = -6.47 to -2.74, t[913] = -4.82, p < .001, r = 




 = .59; marginal R
2
 = .16). Within the CU group we found a significant effect 
for probability of loss (ß = -2.97, 95%CI = -4.48 to -1.47, t[1281] = -3.86, p = .000, r = .107). In 
contrast, there was no effect of gain (ß = .25, 95%CI = -1.08 to 1.58, t[1281] = .36, p = .714, r = 





 = .05). Together, these results suggest that CU were predominantly sensitive to 
probability of loss, while controls were sensitive also to gain and loss information.  
  
3.2.3. Impact of demographic, cognitive, and clinical variables on gain, loss and 
probability of loss sensitivities 
To examine whether the reported group differences (Table 1) relate to differential 
weighing of gain, loss, and probability of loss information, we used hierarchical linear models. 
Since the SWM Strategy score and the SWM Total error score revealed large effect sizes, as well 
as the BIS total score and the ADHD sum score, these variables were entered into separate 
models (see Supplementary Table S1). As shown in Table 3, gain and loss sensitivity were best 
explained by a model that included group and years of school education (F[93]=8.36; R
2
=.134; 
p=.055; and F[93]=4.12; R
2
=.61; p=.054, respectively), suggesting that longer education leads to 
higher sensitivity to gains and losses. With regard to probability of loss sensitivity, we found that 
the model with group, IQ, SWM Strategy score, and ADHD symptoms explained more variance 
than the other models (Table 3) (F[91]=5.40; R
2
=.156; p=.053). Additional multiple regressions 
did not reveal any effect for sex and age. Together, these data suggest that while gain sensitivity 
was explained primarily by cocaine use status (and also by years of school education), loss and 
probability of loss sensitivity were better explained by additional demographic, cognitive (i.e., 
executive functioning and working memory) and clinical variables.  
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------------------ TABLE 3 ------------------ 
 
Next, we aimed to investigate how gain, loss, and probability of loss sensitivity correlate 
with risk-attitude in each decision scenario, after correcting for the significant effects found in 
the best explanatory hierarchical linear models (Table 4). Specifically, gain and loss correlations 
were corrected for years of school education and probability of loss correlations were corrected 
for IQ, executive functioning, and ADHD symptoms. Our data revealed that, within the control 
group, in the most and the least favourable decision scenarios, risk-attitude correlated with the 
sensitivity to gain, loss and probability of loss information. However, within the CU group, only 
sensitivity to gain and loss correlated with risk-attitude in the least favourable decision scenario, 
while only the sensitivity to probability of loss correlated with risk-attitude in the most 
favourable decision scenario. 
 
------------------ TABLE 4 ------------------ 
 
3.2.3. Impact of cocaine use severity on gain, loss and probability of loss sensitivities  
Finally, we investigated possible associations of gain, loss, and probability of loss 
sensitivity with cocaine-related metabolites and self-reported cocaine consumption in CU. We 
found no effect for the self-reported estimated cumulative lifetime dose of cocaine, abstinence 
period and years of cocaine consumption. In contrast, benzoylecgonine (r=-.298, p=.025, n = 56), 
norcocaine (r=-.302, p=.023, n = 56) and cocaine (r=-.278, p=.037, n = 56) metabolites, as well 
as the sum of these three metabolites, Cocainetotal (r=-.291, p=.029, n = 56), correlated negatively 
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with probability of loss sensitivity. This finding indicates that severe cocaine consumption 
coincides with lower probability of loss sensitivity. However, these effects did not remain 
significant after including IQ, executive functioning, and ADHD symptoms in the model, in 
accordance with the hierarchical linear models (Table 3). Regarding gain and loss sensitivity, no 
effect was found for the self-reported estimated cumulative lifetime dose of cocaine, abstinence 
period, years of cocaine consumption, or cocaine metabolites (with and without including years 




Our study extends current knowledge on decision-making deficits in CU by analysing 
risky decisions with a more fine-grained approach in the context of the CCT. We investigated 
whether chronic CU differed from stimulant-naïve controls in the use of gain, loss, and 
probability of loss information during decision-making under risk. CU were more risk-seeking 
than controls in less favourable decision scenarios, where returns were low and risk was high 
(i.e., lower expected value). By looking at the use of information over all decision scenarios, the 
data confirmed our hypothesis that chronic CU are not as sensitive to gains as stimulant-naïve 
controls. Indeed, CU were less sensitive to the expected value, suggesting that they are not able 
to fully integrate all of the available information. We also found a marginally significant group 
effect for loss sensitivity; however, no group effect was found for probability of loss sensitivity. 
Furthermore, the main group difference in gain sensitivity was not explained by additional 
predictors (i.e., IQ, executive functioning, working memory, visual processing efficiency, 
impulsivity traits or ADHD symptoms), although years of school education also had an effect. 
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By contrast, loss sensitivity was related to years of education, but not group and, for probability 
of loss sensitivity, we found an effect for IQ, executive functioning and ADHD symptoms, but 
not for group. Finally, the correlation analyses between risk-attitude and the sensitivity to gain, 
loss, and probability of loss showed that, relative to stimulant-naïve controls, chronic CU more 
often fail to consider all available information on returns (i.e., gain and loss) and probability of 
loss.  
From a clinical perspective, the reduced gain sensitivity in CU is not surprising, since one 
of the core criteria of all substance-related disorders is the withdrawal from social, occupational, 
and recreational activities with high value in order to use the substance [58]. This pattern of 
behaviour has been proposed to reflect a shift in the subjective value of ordinary life events to 
substance-related rewards [23]. Our study suggest that this shift extends to the domain of taking 
risks in well-controlled laboratory settings.   
In contrast to reduced gain sensitivity in the CU group, loss and probability of loss 
sensitivity were better explained by demographic and intellectual differences as well as 
psychiatric comorbidities than by chronic cocaine use. These results demonstrate that the 
interpretation of deficits in decision-making findings needs to take the specific demographic and 
clinical background  that which is typically associated with cocaine-related disorder [59]. Given 
that, within the CU group, 90% met the criteria for current or past cocaine dependency or abuse 
according to DSM-IV-R, we expected to find higher self-reported impulsivity and ADHD 
symptoms and worse general cognitive performance in the CU than the control group. Although 
our findings suggest that severe cocaine use is not directly linked to a decrease in sensitivity to 
loss and probability of loss information, they nevertheless point at impairments of CU in the 
processing of loss and probability of loss information. 
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Our data also suggest that CU may not integrate all the available information as fully as 
controls when making risky decisions, as shown by the interaction effect of group and expected 
value on risky behaviour. Such impairments in integrating all of the available information could 
be related to vmPFC dysfunction, as this brain region has been associated with the integration of 
subcortical signals within a single representation of net value, which is accumulated over time 
until the individual decides to accept or reject an option [60]. Indeed, in the Iowa Gambling 
Task, CU showed impaired performance that resembled the maladaptive behaviour of patients 
with vmPFC lesions [61, 62]. More specifically, CU also showed reduced vmPFC activation to 
social and object reward [27], in line with a gain processing function of this region and mirroring 
the reduced gain sensitivity of CU found in the current study.  
Of note, it has been recently shown that individuals with opiate dependence also differ in 
their use of available information during decision making, relative to controls [53]. In that study, 
heroin-dependent patients took more risks than controls irrespective of whether the situation was 
favourable or unfavourable, suggesting that heroin users may not attend to environmental 
contingencies when making decisions [53]. Although we cannot generalize to other substance 
use disorders, our findings support the hypothesis that deficits in integrating the available 
information when making decisions might be investigated as a general behavioural marker for 
severe substance use disorders. 
Some limitations should be considered when interpreting our findings. First, the cross-
sectional design of this study does not allow us to clearly determine the causal relationship 
between cocaine use and alterations in gain sensitivity, especially because we found no 
correlation with subjective and objective cocaine use severity markers. Accordingly, it is also 
possible that a lower sensitivity to gain predicts the onset of substance use. Nevertheless, it 
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seems to be more likely that variations in loss and probability of loss sensitivities precede 
chronic cocaine use, as indicated by the significant effects of demographic, clinical, and 
cognitive variables (i.e., performance on tests of executive function and working memory). 
Future studies might consider investigating whether changes in cocaine consumption can affect 
sensitivity to gain, loss, and probability of loss information during decision-making. 
Remarkably, this finding complements one of our previous studies that investigated decision-
making under risk without feedback using a different definition of risk and found that risk 
proneness was associated with higher cocaine concentrations in the hair [63]. The different 
definition of risk may also explain why, in contrast to Wittwer, et al. [63], we found an effect of 
IQ, executive functioning, and ADHD symptoms on risk in terms of probability of loss 
sensitivity, but no effect for sex and age. Finally, our data (see Figure 1) and the hierarchical 
multiple regressions (see Table 3) showed only small-to-medium effect sizes for risk-taking and 
several marginal differences with low R
2
. This may suggest that substantial variance in 
information sensitivity arises from individual differences or additional uncontrolled variables. 
Having said this, we also found converging evidence for a significant effect of cocaine use on 
gain sensitivity with the linear-mixed model (see Figure 2), which accounts for individual 
differences.  
Taken together, our findings open avenues for future applied research that aims to 
improve the efficiency and the efficacy of preventive and therapeutic strategies for chronic 
substance users. For instance, decreased sensitivity to gain might partially explain the lack of 
adherence to long-term treatments and detoxification programs, since chronic CU are insensitive 
to the advantages of maintaining abstinence. In addition, our findings support the necessity of 
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considering demographic, clinical, and cognitive variables when providing therapeutic strategies, 
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Figure 1. Average number of cards selected in each scenario. EV, Expected Value. Effect sizes 
|r|<.10 correspond to small effects; .10≤|r|<.30 to medium effects; .30≤|r|<.50 to large effects. ** 
p-value <.01. 
 
Figure 2. Regression coefficients for the main fixed effects and interactions of the linear mixed 
model. The model included random slopes and intercepts for each participant and each scenario 
property (i.e. gain, loss and probability of loss). Stimulant-naïve control group, at low gain, low 
loss and low probability of loss served as reference group. Of note, CU were less sensitive to 
gain than control participants. “Cocaine Group” refers to the main effect of group on the overall 
number of cards chosen. “Cocaine Group : High Gain” refers to the interaction effect of the 
variable group and the gain information; “Cocaine Group : High Loss”, refers to the interaction 
effect of the variable group and loss information; “Cocaine Group : High Risk” refers to the 
interaction effect of the variable group and risk information. Conditional R
2
 = .54, marginal R
2
 = 






Table 1.  
Demographic, cognitive and clinical data.  
  Controls (n=40) Cocaine Users (n=56) Test Statistics df p 
Demographics      
     Age, y 29.3 (7.1) 32.3 (7.9) t = -1.9 89.0 .060 
     Sex, f/m 17 / 23 17 / 39 x² = 1.5 1 .220 
     Verbal IQ a 100.6 (6.5) 95.4 (5.8) t = 3.9 77.7 .000 
     School education, y 10.2 (1.4) 9.4 (.89) W = 1415 - .009 
 Cognition          
      SWM - Between errors 15.9 (13.7) 26.0 (17.3) W = 723 - .003 
      SWM - Within errors .85 (2.3) 1.1 (2.1) W = 952 - .151 
      SWM - Total errors  16.3 (14.1)  26.4 (17.4)  W = 729 - .003 
      SWM - Strategy score  29.0 (6.4) 32.5 (5.8)  t = -2.7 78.9  .007 
      RVP - Response A’ .92 (.06) .88 (.05) W = 1638 - .000 
      RVP - Response bias B’ .89 (.32)  .93 (.10) W = 1121 - .655 
      RVP - Mean latency, ms. 405.9 (196.1) 425.4 (91.4) t = -.94 76.1 .350 
      RVP - Total false alarms  1.2 (1.4)  2.3 (5.2) W = 835  - .028 
      RVP - Impulsivity Index  .00 (.93) .66 (3.5) W = 1005 - .392 
      RVP - Efficiency Index .00 (1.7)  -1.0 (4.1)  W = 1477 - .007 
      MTS - Correct, %  96.1 (5.0) 93.8 (6.8)  W = 1306 - .097 
      MTS - Correct reaction time, ms.  2568 (623.9)  2662 (737.3)  t = -.67 90.8 .504 
      MTS - Time change 2-8, ms.  146.0 (303.5)  139.2 (434.2)  W = 1193 - .480 
      MTS - Impulsivity Index .00 (1.5) -.29 (3.1) t = .61 84.3 .543 
      MTS - Efficiency Index .00 (1.3) -1.1 (2.9) t = 2.55 80.2 .012 
 BIS subscales          
     Total Score  64.2 11.1  70.0 12.0  t = -2.4 87.8  .016 
     Attention Impulsiveness 14.6 (3.8) 16.9 (4.4)  t = -2.7 90.6 .007 
     Motor Impulsiveness 23.4 (5.1) 24.4 (5.2) t = -.94 85.0 .346 
     Non-planning Impulsiveness 26.1 (4.8) 28.6 (4.9) t = -2.4 84.8 .014 
Clinical       
     ADHD, y/n b 7/33 43/13 x² = .46 1 .496 
     ADHD sum score 10.5 (9.7) 14.6 (10.1) W = 827 - .029 
Note. Table reports counts or means with standard deviations in brackets. Significant group differences are shown in bold. t = 
Student t-test; x2 = Pearson chi-square; W = Wilcoxon rank sum test. (a) Verbal intelligence quotient estimated by the 
Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B); (b) Cut-off DSM-IV criteria as assessed by the ADHD-SR questionnaire. 
RVP, Rapid Visual Information Processing task; SWM, Spatial Working Memory task; MTS, Match to Sample Visual Search 
task. BIS, Barratt Impulsiveness Scale. ADHD, Attention deficit hyperactivity disorder.  
 
  
Table 2.  
 Substance use related disorders and drug consumption pattern. 
      
  Controls (n=40) Cocaine Users (n=56) Test Statistics df p 
Nicotine      
     Smoking, y/n 37/3 53/3 x² = .18 1 .668 
     Cigarettes per week a 67.0 (47.1) 111.6 (68.2) W = 575.5 - .000 
     Years of use 11.7 (6.1) 17.2 (16.1) W = 710 - .026 
Alcohol      
     Times per week a 2.7 (2.2) 3.3 (3.5) W = 1052 - .719 
     Grams per week a, b 22796 (24922) 59247 (117708) W = 972 - .334 
     Years of use 14.1 (6.9) 16.8 (7.0) t = -1.88 84.81 .062 
     Estimated cumulative lifetime dose, g b 65609 (51775) 284749 (428576) W = 707 - .002 
Cocaine          
     Cocaine lifetime experience, y/n c 5/35 56/0 - - - 
     Times per week a  -  2.4 (2.4)  -  - - 
     Grams per week a  -  3.9 (5.76)  -  - - 
     Years of use  -  12.0 (7.5)  -  - - 
     Estimated cumulative lifetime dose, g   -  1919 (2290)  -  - - 
     Abstinence period, days  -  14.3 (23.7)  -  - - 
     Cocaine, ng/mg in hair [n] d  - 19388 (26967) [56]  -  - - 
     Benzoylecgonine, ng/mg in hair [n] d  -  11197 (15907) [56]  -  - - 
     Cocaethylene, ng/mg in hair [n] d  - 960.8 (1943) [50]  -  - - 
     Norcocaine, ng/mg in hair [n] d  -  447.8 (654.5) [56]  -  - - 
     Cocainetotal, ng/mg in hair [n] d, e  - 31034 (41770) [56]  -  - - 
     Urine toxicology, n/p in hair [n] f 40/0 33/22   x² = 33.5  2 .000 
Cannabis          
     Cannabis lifetime experience, y/n c 35/5 50/6 x² = .07 1 .395 
     Grams per week a  .86 (1.9) 2.0 (7.0)   W = 798 - .493 
     Years of use  7.8 (6.0)  12.7 (9.0)  W = 594 - .012 
     Estimated cumulative lifetime dose, g  142.8 (370.0)  3341 (5608)  W = 385 - .000 
     Abstinence period, days  1159.0 (2222.1) 1005 (2216)   W = 1012 - .221 
     THC, ng/mg in hair [n]  36.4 (43.5) [5]  137.0 (258.9) [16]  W = 26.5  - .264 
     CBD, ng/mg in hair [n]  16.0 (-) [1] 32.1 (35.8) [8]  W = 4  - 1 
     CBN, ng/mg in hair [n]  16.6 (18.7) [3]  54.5 (74.5) [14]  W = 14  - .376 
     Urine toxicology, n/p f  38/2 46/10   x² = 5.4  - .066 
MDMA          
     MDMA lifetime experience, y/n c 9/31 49/7 x² = 41.2 1 .000 
     Grams per week a .00 (-) [1] .04 (.08) W = 131 - .054 
     Years of use 1.8 (1.6) 7.8 (7.6) W = 108 - .015 
     Estimated cumulative lifetime dose, g .34 (.46) 50.4 (154.1) W = 40.5 - .000 
     Abstinence period, days 1771 (3033) 993.5 (1965.9) W = 233.5 - .780 
     MDMA, ng/mg in hair [n] d 109.0 (55.5) [4] 2579 (4976) [36] W = 38.5 - .130 
     MDA, ng/mg in hair [n] d 6.6 (3.0) [3] 189.2 (436.4) [29] W = 19.5 - .120 
Amphetamine      
     Amphetamine lifetime experience, y/n c 4/36 42/14 x² = 39.5 1 .000 
     Grams per week a .01 (.02) .17 (.63) W = 54 - .241 
     Years of use .04 (.08) 7.4 (6.5) W = 7.5 - .002 
     Estimated cumulative lifetime dose, g 2.1 (3.8) 162.8 (369.8) W = 39 - .079 
     Abstinence period, days 1771 (3033) 993.5 (1965.9) W = 233.5 - .780 
     Amphetamine, ng/mg in hair [n] d - (-) [0] 1222 (1700) [13] - - - 
SCID-I diagnosis      
     Alcohol dependency current, y/n 0/40 8/48 x² = 6.2 1 .012 
     Alcohol dependency past, y/n 0/40 18/38 x² = 15.8 1 .000 
     Alcohol abuse current, y/n 1/39 18/38 x² = 12.9 1 .000 
     Alcohol abuse past, y/n 4/36 26/30 x² = 14.4 1 .000 
     Cocaine dependency current, y/n 0/40 36/20 x² = 41.1 1 .000 
     Cocaine dependency past, y/n 0/40 39/17 x² = 46.9 1 .000 
     Cocaine abuse current, y/n 0/40 36/20 x² = 41.1 1 .000 
     Cocaine abuse past, y/n 0/40 36/20 x² = 41.1 1 .000 
     Cannabis dependency current, y/n 0/40 1/55 x² = .72 1 .395 
     Cannabis dependency past, y/n 0/40 9/46 x² = 7.2 1 .007 
     Cannabis abuse current, y/n 0/40 4/52 x² = 2.9 1 .084 
     Cannabis abuse past, y/n 5/35 17/38 x² = 4.4 1 .035 
Note. Table reports counts or means with standard deviations in brackets. Significant differences are shown in bold. t = Student t-test; 
x2 = Pearson chi-square; W = Wilcoxon rank sum test. Here we specifically reported the most prevalent substances and metabolites: 
THC, Tetrahydrocannabinol; CBD, cannabinoid; CBN, cannabinol; MDMA, 3,4-Methylenedioxymethamphetamine; MDA, 3,4-
Methylenedioxyamphetamine; SCID-I, Structured Clinical Interview for DSM-IV Axis I Disorders. (a) Average use of the current 
consumption period. (b) Pure alcohol estimation; (c) Self-report: Have you ever consumed this substance, at least once, in your life? (d) 
Cut-off values for cocaine = 500 pg/mg and for amphetamines/MDMA = 200 pg/mg (Cooper et al., 2012). (e) Cocainetotal (= Cocaine 
+ Benzoylecgonine + Norcocaine) is a more robust procedure for discrimination between incorporation and contamination of hairs 
(Hoelzle et al., 2008). (f) Urine toxicology (neg/pos) are based on cut-off value for Cocaine = 150 ng/ml and for Tetrahydrocannabinol 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.  
Correlations between gain, loss and risk sensitivity and risk-attitude at each decision scenario.  
 Non-Stimulant Controls  Cocaine Users 
 Gain a Loss a Risk b  Gain a Loss a Risk b 
 Average no of cards        
     Scenario 1 .538 *** .559 *** -.583 ***  .193 .184 -.554 *** 
     Scenario 2 -.135 -.239 -.503 **  -.416 ** .012 -.472 *** 
     Scenario 3 -.011 -.394 * -.144  -.157 -.320 * -.485 *** 
     Scenario 4 .456 ** -.574 *** .099  -.406 ** -.455 *** -.357 ** 
     Scenario 5 .088 -.217 .258  .025 .203 .094 
     Scenario 6 -.530 *** -.402 * .417 *  -.557 *** -.067 .125 
     Scenario 7 -.244 -.591 *** .465 **  -.057 -.510 *** .060 
     Scenario 8 -.439 ** -.743 *** .469 **  -.523 *** -.338 * .120 
Note. p-value < .05 *; p-value < .01 **; p-value < .001 ***. (a) Corrected for years of school education; (b) 





Sensitivity to gains during risky decision-making differentiates 
chronic cocaine users from stimulant-naïve controls 
 
Kluwe-Schiavon, B.*,1; Kexel, A.1; Manenti, G.1,2; Cole, D.1,3.; Baumgartner, M.R.4 





Materials and Methods 
 
Procedure 
Data were collected at the Psychiatric Hospital of the University of Zurich. CU were 
recruited from treatment centres for addiction in and around the Canton of Zurich, Switzerland. 
The testing sessions started either at 09:00am or noon and lasted for around five hours. Participants 
were asked to abstain from illegal substances for a minimum of 72h and from alcohol for at least 
24h before the session. Each participant was tested individually and anonymously. All clinical and 
cognitive assessments were performed by trained psychologists or students in psychology who 
were supervised by a clinical psychologist. 
 
Hair toxicological analysis 
A total of 98 compounds and metabolites were accessed, as shown in Table S2. For a 
complete description of our routine protocol and methodological adaptations, please see Vonmoos 
et al. (2013), Scholz et al. (2019), and Scholz et al. (submitted) respectively. 
 
Table S2. 
Complete list of compounds (metabolites) accessed. 
















































































































General cognitive assessment 
In addition to the estimate of premorbid verbal intelligence measured by the German 
vocabulary test Mehrfachwahl-Wortschatz-Intelligenztest (Lehrl, 1999), general cognitive 
performance was assessed with a selection of three tasks from the Cambridge Neuropsychological 
Test Automated Battery (CANTAB, http://www.cantab.com): the Spatial Working Memory task 
(SWM), assessing working memory and executive functioning; the Match to Sample Visual Search 
task (MTS), a visual matching test involving a speed-accuracy trade-off; and the Rapid Visual 
Information Processing task (RVP), assessing sustained attention capacity. 
The Spatial Working Memory task (SWM) was used to assess spatial working memory and 
executive functioning. In this task a number of coloured boxes are shown on the screen. 
Participants should find a yellow ‘token’ in one of the boxes and use them to fill up an empty 
column on the right-hand side of the screen. Depending on the difficulty level used for this test, 
the number of boxes can be gradually increased until a maximum of 12 boxes. We measured 
between-search errors (occasions the participant returned to search a box in which a token had 
already been found during a previous search sequence), within-search errors (occasions the 
participant revisited a box already found to be empty during the same search sequence), total 
errors, and a strategy score (number of times the participant began a new search with a different 
box to the last search; therefore, a high score indicated an inefficient strategy).  
The Match to Sample Visual Search task (MTS) is a visual matching test involving a trade-
off of speed and accuracy. In this task the sample stimulus is an abstract pattern displayed within 
a red square in the middle of the screen. After a brief delay, a varying number of similar patterns 
(1, 2, 4 or 8) is shown in a circle of boxes around the edge of the screen. Only one of these patterns 
 4 
matches the pattern in the centre of the screen. The subject must select the matching stimulus by 
touching it. The task provides three major measures: the percentage of correct responses, the mean 
latency of correct responses (the time taken to respond to trials correctly), and the mean change in 
movement time between trials with 2 and 8 choices (mean movement time in trials with 8 choices 
minus trials with 2 choices).  
The Rapid Visual Information Processing task (RVP) was designed to assess sustained 
attention capacity. In this task, a white box appears in the centre of the screen, inside which single 
digits appear in a pseudo-random order, at the rate of 100 digits per minute. Subjects are requested 
to detect target sequences of digits (for example, 2-4-6, 3-5-7, 4-6-8) and to register responses 
using the press pad. The task provides the following measures: total false alarms (occasions the 
participant responded inappropriately), response A’ (a signal detection measure of the sensitivity 
to the target) response bias B’ (a signal detection measure of the strength of trace required to elicit 
a response), and mean latency for correct responses (mean time taken to respond correctly).  
Moreover, based on our previous work, we calculated the Impulsivity index and the 
Efficiency index for the MTS and RVP (Quednow et al., 2007, Vonmoos et al., 2013). The 
Impulsivity index is a score quantifying the behavioural dimension of “fast and inaccurate” vs. 
“slow and accurate”. For the RVP, this score was obtained by subtracting the z-standardized score 
of the mean latency over all responses from the z-standardized score of the total of false alarms, 
while for the MTS, this index was obtained by subtracting the z-standardized score of the overall 
reaction time from the z-standardized score of the total of errors committed. The Efficiency index 
is a score quantifying the “fast and accurate” vs. “slow and inaccurate” dimension, and was 
obtained from the RVP by summing the z-standardized score of the total of false alarms committed 
and the z-standardized score of the mean latency over all responses and multiplying the sum with 
–1. Similarly, for the MTS, this score was obtained by summing the standardized score of the total 
of errors committed and the standardized score of the overall reaction time and multiplying the 
sum with –1. The false alarms and latency values from the RVP and the errors committed and the 
reaction time from the MTS of all participants were standardized to the means and standard 
deviations of the control group. The Meta-Efficiency Index was calculated by taking the average 
of both Efficiency indices. Previous work from our group has shown that, in a visual search task, 
a similar impulsivity index can distinguish MDMA users from controls (Quednow et al., 2007), 
although in the RVP task we found no impulsivity index differences between cocaine users and 
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stimulant-naïve controls (Vonmoos et al., 2013). Finally, a Meta-Efficiency Index was calculated 
by taking the average across the Efficiency indices of both the MTS and the RVP.  
 
 
The Columbia Card Task 
In the no-feedback version of the CCT participants were explicitly instructed to perform 
each round independently from the previous one, because at the end of the task three rounds would 
be randomly selected to calculate the payoff. The eight decision scenarios were repeated three 
times and randomly presented within three blocks, for a total of 24 rounds. In this version of the 
CCT, participants did not receive any feedback about their performance until the end of the 24 
rounds, when three rounds were randomly selected by the computer and the sum of the points 
made in these rounds was converted to actual money for the participant (1 point = 0.10 CHF).  
 
Risk-attitude 
Given that both the gain and the likelihood of experiencing a loss increased with each card 
turned over by the computer, choosing more cards to be turned over is associated with greater 
outcome variability and, therefore, was a riskier strategy than turning over fewer cards. Thus, in 
the risk-attitude analysis we determined risk-seeking propensity independently from the influence 





Table S1.  
Spearman’s rank correlations between all predictors included in the hierarchical multiple linear regression models. 
 Years of  
Education 







Years of education 1 - - - - - - 
IQ .261 ** 1 - - - - - 
SWM Strategy -.307 ** -.133 1 - - - - 
SWM Total Errors -.233 * -.166 .774 *** 1 - - - 
Efficiency Index a .173 .125 -.389 *** -.372 *** 1 - - 
Impulsivity Index a -.120 .029 .088 .044 -.012 - - 
BIS -.199 -.042 .173 .117 -.095 1 - 
ADHD -.162 -.037 .176 .100 -.163 .497 *** 1 
Note. Correlations were performed within the total sample (n = 96). YE, Years of Education; IQ, Intelligence Quotient assessed with the 
Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B); EF, Executive Functioning assessed with the Strategy score from the Spatial 
Working Memory task (SWM); WM, Working Memory assessed with the Total Errors from the Spatial Working Memory task; BIS, 
total sum score from Barratt Impulsiveness Scale; ADHD, Attention deficit hyperactivity disorder total sum score from ADHD self-rating 
scale. p-value < .05 *; p-value < .01 **; p-value < .001 ***. (a) Efficiency Index is the average of the efficiency indices from the Rapid 







Lehrl, S. (1999). Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B). Hogrefe. 
Quednow, B. B., Kuhn, K. U., Hoppe, C., Westheide, J., Maier, W., Daum, I. & Wagner, M. 
(2007). Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA 
("Ecstasy"). Psychopharmacology (Berl) 189, 517-30. 
Scholz, C., Quednow, B. B., Herdener, M., Kraemer, T. & Baumgartner, M. R. (2019). Cocaine 
Hydroxy Metabolites in Hair: Indicators for Cocaine Use Versus External Contamination. J Anal 
Toxicol. 
Vonmoos, M., Hulka, L. M., Preller, K. H., Jenni, D., Schulz, C., Baumgartner, M. R. & 
Quednow, B. B. (2013). Differences in self-reported and behavioral measures of impulsivity in 
recreational and dependent cocaine users. Drug and Alcohol Dependence 133, 61-70. 
Vonmoos., Hulka., Preller., Jenni., Baumgartner., Stohler., Bolla. & Quednow. (2013). 
Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit 
hyperactivity disorder, craving and early age at onset. Br J Psychiatry 203, 35-43. 
 
